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Abstract
The most active estrogen, 17b-estradiol (E2), has previously been shown to
stimulate a female sex-specific antisecretory response in the intestine. This
effect is thought to contribute to the increase in whole body extracellular
fluid (ECF) volume which occurs in high estrogen states, such as in the
implantation window during estrous cycle. The increased ECF volume may
be short-circuited by a renal compensation unless estrogen exerts a proab-
sorptive effect in the nephron. Thus, the effect of E2 on ENaC in kidney
cortical collecting duct (CCD) cells is of interest to understand estrogen reg-
ulation of ECF volume. Previous studies showed a rapid stimulatory effect
of estrogen on ENaC in bronchial epithelium. In this study we examined if
such a rapid effect on Na+ absorption could occur in the kidney. Experi-
ments were carried out on murine M1-CCD cell cultures. E2 (25 nmol/L)
treatment caused a rapid-onset (<15 min) and sustained increase in the
amiloride-sensitive Na+ current (INa) in CCD monolayers mounted in
Ussing chambers (control, 1.9  0.2 lA/cm2; E2, 4.7  0.3 lA/cm2; n = 43,
P < 0.001), without affecting the ouabain-sensitive Na+/K+ pump current.
The INa response to E2 was inhibited by PKCd activity antagonism with rot-
tlerin (5 lmol/L), inhibition of matrix metalloproteinases activity with
GM6001 (1 lmol/L), inhibition of EGFR activity with AG1478 (10 lmol/L),
inhibition of PLC activity with U-73122 (10 lmol/L), and inhibition of
estrogen receptors with the general ER antagonist ICI-182780 (100 nmol/L).
The estrogen activation of INa could be mimicked by the ERa agonist PPT
(1 nmol/L). The nuclear excluded estrogen dendrimer conjugate (EDC)
induced similar stimulatory effects on INa comparable to free E2. The end
target for E2 stimulation of PKCd was shown to be an increased abundance
of the c-ENaC subunit in the apical plasma membrane of CCD cells. We
have demonstrated a novel rapid “nongenomic” function of estrogen to
stimulate ENaC via ERa-EGFR transactivation in kidney CCD cells. We pro-
pose that the salt-retaining effect of estrogen in the kidney together with its
antisecretory action in the intestine are the molecular mechanisms causing
the expanded ECF volume in high-estrogen states.
Introduction
17b-estradiol (E2) is the major estrogen naturally occur-
ring in the female body. Our laboratory has provided
evidence showing that E2 produces an antisecretory effect
in the distal colon of female rats (O’Mahony et al. 2007).
The antisecretory response to E2 has a short-term (non-
genomic) and a long-term (genomic) component. The
short-term component involves activation of protein
kinase C delta (PKCd) and subsequent inhibition of the
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basolateral K+ channel KCNQ1:KCNE3 and the long-term
component involves changes in the trafficking of KCNQ1
and the expression of transporter proteins necessary for
Cl secretion (O’Mahony et al. 2009). The antisecretory
response to E2 could provide an explanation for salt and
fluid retention observed in females during states of high
circulating levels of estrogen during phases of the estrous
cycle (Crocker 1971) and pregnancy. Extracellular fluid
expansion has physiological relevance for the endometrial
swelling and restructuring that occurs in advance of
embryo implantation and could also impact upon cardio-
vascular function.
The antisecretory effects of E2 in the intestine may be
short-circuited by compensatory Na+ and water excretory
mechanisms in the kidney and it has been proposed but
not yet confirmed that estrogen may exert a proabsorptive
effect in this organ.
In the kidney, specifically at the aldosterone-sensitive
distal nephron (ASDN), the reabsorption of Na+ is medi-
ated by the activity of the epithelial Na+ channel (ENaC).
This channel belongs to the ENaC/degenerin family of
ion channels and is composed of three structurally related
subunits termed a, b, and c (Rossier and Stutts 2009).
ENaC is expressed at the apical membrane of the princi-
pal cells in the ASDN and the channel activity is regulated
by hormones such as vasopressin and aldosterone (Lee
et al. 2008; Bubien 2010; Butterworth 2010; Thomas and
Harvey 2011). There is compelling evidence suggesting
that the activity of ENaC could also be regulated by E2 in
the kidney. In ovariectomized rats, E2 raises plasma Na+
concentration (Zheng et al. 2006) and increases renal
a- and b-ENaC subunit mRNA levels (Gambling et al.
2004; Riazi et al. 2006). In mouse collecting duct cells, E2
increases the activity of ENaC (Chang et al. 2007).
Strengthening this idea, similar effects have been
described in nonrenal cell types such as rat alveolar epi-
thelial cells and osteoblasts, where E2 increases the activ-
ity, mRNA and protein abundance of ENaC (Sweezey
et al. 1998; Laube et al. 2011; Yang et al. 2011; Greenlee
et al. 2013).
On the basis of this evidence, we reasoned that in addi-
tion to the gender-specific antisecretory effect of E2
observed in distal colon, a putative proabsorptive effect of
E2 in the kidney, specifically in the CCD cells, could
provide an additional mechanism to explain salt and fluid
retention observed in females during periods of high
circulating levels of E2.
To test the hypothesis for a proabsorptive effect of E2
we used the renal cortical collecting duct M1 cell line
(M1-CCD) as a model for Na+-absorbing principal cells.
We investigated the effect of E2 on the amiloride-sensitive
short-circuit current, ENaC subunit trafficking and poten-
tial protein kinase regulatory signaling pathways.
Materials and Methods
Cell culture
The M1 cortical collecting duct cell line (M1-CCD) was
obtained from ATCC (CRL-2038). This cell line was
derived from renal CCD tubules microdissected from a
transgenic mouse containing the early region of SV40
virus (strain Tg [SV40E] Bri7) (Stoos et al. 1991).
M1-CCD cells were cultured in 75 cm2 or 25 cm2 poly-
styrene flasks containing a mixture of 1:1 Dulbecco’s
modified Eagle’s medium and Ham F-12 medium
(DMEM:F-12) with fetal bovine serum (5%); supple-
mented with L-glutamine (2 mmol/L), penicillin (100
l/mL)/streptomycin (100 lg/mL), and dexamethasone
(5 lmol/L). Cells were maintained in atmosphere of 5%
CO2, 37°C, and 70% humidity. Culture medium was
changed every 3 days and cells were subcultured when
they became 70% confluent. M1-CCD cells were main-
tained in serum-free medium and in the absence of
dexamethasone overnight before treatment with E2.
Western blotting
Cell lysates were dissolved by boiling in Laemmli sample
buffer (Sigma-Aldrich Ireland Limited, Arklow, Ireland)
and proteins were separated by SDS-PAGE on 8% (w/v)
polyacrylamide gels. The proteins were transferred onto
nitrocellulose membranes, and probed with the specified
primary antibodies diluted in 5% (w/v) skimmed milk or
bovine serum albumin (BSA) in TBS 0.1% Tween20,
according to the supplier’s instructions. Primary antibodies
used were mouse anti-b-actin (dilution 1:5000) (Sigma-
Aldrich Ireland Limited), rabbit anti-phospho-PKCd
(Ser643) (dilution 1:1000) (Cell Signaling Technology,
Brennan & Co., Dublin, Ireland), rabbit anti-a-ENaC
(dilution 1:500) (Millipore, Millipore Cork, Ireland, Cat. #
AB3530P), rabbit anti-b-ENaC (dilution 1:500) (Abcam,
Cat. # ab2906), rabbit anti-c-ENaC (dilution 1:500) (Ab-
cam, Mayo, Ireland, Cat. # ab3468), mouse antiestrogen
receptor a (dilution 1:1000) (Cell Signaling Technology),
and rabbit antiestrogen receptor b (dilution 1:1000) (Cell
Signaling Technology). Bound antibodies were detected
using anti-rabbit IgG, HRP-linked (dilution 1:5000)
(Cell Signaling Technology) or anti-mouse IgG, HRP-
linked (dilution 1:5000) (Cell Signaling Technology);
antibody-labeled proteins were visualized by enhanced
chemiluminescence, ECL+ (Amersham Biosciences,
Buckinghampshire, UK). Exposed films were digitally pho-
tographed and subjected to densitometric analysis using
GeneSnap software (Synoptics Ltd, Cambridge, UK).
The ENaC antibodies used in our study have been
reported by others as specific for the different ENaC
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subunits (Butterworth et al. 2005a,b; Zhou et al. 2006;
Portela-Gomes et al. 2008; Chen et al. 2009; Li et al.
2009; Rubenstein et al. 2011). Moreover, our Western
blots demonstrated the predicted molecular weight for all
the different ENaC subunits tested here (Fig. 1).
Biotinylation
M1-CCD cells were grown on inserts of 4.2 cm2 area (Mil-
lipore, Hanging Cell Culture Inserts) until a transepithelial
resistance >2 kΩ cm2 was reached. After E2 treatment, cell
monolayers were washed twice with ice-cold PBS and
placed on ice. Sulfo-NHS-Biotin (Fisher Scientific Ireland,
Dublin, Ireland) solution was prepared in PBS at a concen-
tration of 1 mg/mL and applied on the apical side. Cells
were incubated with this solution twice for 15 min on ice
and then washed with PBS, followed by 15 min incubation
with 100 mmol/L glycine. Cells were then washed with PBS
and lysed. The amount of protein in each sample was quan-
tified and between 300 and 500 lg protein was incubated
with streptavidin-agarose beads (Fisher Scientific Ireland)
overnight at 4°C. The next day samples were centrifuged
for 2 min (2500g at 4°C), the supernatant was discarded
and pellets were washed in lysis buffer and centrifuged
again for 2 min (2500g at 4°C). The supernatant was dis-
carded and pellets were resuspended in 40 lL 29 Laemmli
buffer. Forty microliters of biotinylated samples and 20–
40 lg of total lysate were run on SDS-PAGE and then
probed according to the Western blotting protocol
described above.
Immunofluorescence and confocal
microscopy
M1-CCD cells were grown on translucent inserts of
0.3 cm2 area (Millipore, Hanging Cell Culture Inserts)
until a transepithelial resistance >0.6 kΩ cm2 was
reached. After the end of each experiment cells were
washed in ice-cold PBS and apically labeled with Alexa
Fluor 633 conjugated to wheat germ agglutinin (Alexa
Fluor 633-WGA, Invitrogen Biosciences Ltd, Dunlaoire,
Ireland) (dilution 1:200 in PBS) for 10 min at 4°C.
Labeling of the apical membrane with Alexa Fluor
633-WGA was performed in advance for cell membrane
disruption in order to stain the apical membrane only.
Then, cells were fixed in 4% paraformaldehyde in PBS
and permeabilized in 0.2% Triton X-100 in PBS. The
nonspecific binding of antibodies and fluorescent conju-
gates were blocked by incubation in 2% BSA in PBS for
1 h. Primary antibodies used were rabbit anti-a-ENaC
(dilution 1:50) (Millipore, Cat. # AB3530P), rabbit anti-
b-ENaC (dilution 1:50) (Abcam, Cat. # ab2906), and
rabbit anti-c-ENaC (dilution 1:50) (Abcam, Cat. #
ab3468). Bound primary antibodies were detected using
a goat anti-rabbit Alexa Fluor 488 conjugate (Invitrogen
Biosciences Ltd). Cells were mounted in Vectashield
(Vector Laboratories, Peterborough, UK) containing 40,6-
diamidino-2-phenylindole (DAPI), and examined using a
Zeiss LSM 710 Meta confocal microscope. Laser excita-
tion wavelengths for DAPI, Alexa Fluor 488, and Alexa
Fluor 633 were 361, 488, and 633 nm, respectively.
Images were captured at 639 magnification.
Transepithelial ion transport studies
M1-CCD cells were grown on inserts exposing an area of
0.6 cm2 (Millipore, Hanging Cell Culture Inserts) until
reach a transepithelial resistance >0.6 kΩ cm2 and then
mounted in Ussing chambers (Physiologic Instruments,
San Diego, CA). The transepithelial potential difference
(Vt) was clamped to 0 mV using an EVC-4000 Voltage/
Current clamp apparatus (World Precision Instruments).
The transepithelial short-circuit current (Isc) required to
clamp Vt at 0 mV was recorded using Ag-AgCl electrodes
in 3 mol/L KCl agar bridges. Apical and basolateral baths
(A) (B)
(C)
Figure 1. Specificity of ENaC antibodies. (A) In total and
biotinylated samples the a-ENaC antibody specifically recognized a
band of approximately 95 kDa which is the molecular weight
predicted for the full unprocessed form of the subunit. (B) In total
and biotinylated samples, the b-ENaC antibody specifically
recognized a band of approximately 110 kDa which is the
predicted molecular weight of the subunit. (C) For total samples the
c-ENaC antibody detected two bands one of approximately 93 kDa,
probably corresponding to the full length form, and other of
approximately 75 kDa which could correspond to either the cleaved
or the full unglycosylated form of the subunit. In biotinylated
samples, the antibody specifically detected a band of 75 kDa.
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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were filled with Krebs’s solution (in mmol/L: 115 NaCl,
25 NaHCO3, 0.4 KH2PO4, 2.4 K2HPO4, 1.2 MgCl2, 1.2
CaCl2, 10 glucose), pH 7.4 maintained at 37°C with a
95% O2/5% CO2 mixture. All mounted monolayers were
allowed to equilibrate for 30–45 min prior to the experi-
ments being performed. The Isc was defined as positive
for cation flow from the apical to basolateral chamber.
The current flowing through ENaC (INa) was recorded as
the amiloride-inhibitable Isc. To investigate the Na+/K+-
ATPase electrogenic pump activity, the apical membrane
was permeabilized with amphotericin B (50 lmol/L) and
NaCl was replaced by an equimolar concentration of
N-methyl-D-glucamine-Cl (NMDG-Cl). Under these
conditions, the ouabain-sensitive Isc provides a measure
of the current generated by the Na+/K+-ATPase pump.
Data analysis
The densitometry for phospho-PKCd and a-, b-, and
c-ENaC subunit bands were normalized to the loading
control b-actin. All data are reported as mean  SEM.
Statistical analysis of the data was performed using a
paired Student’s t-test for analysis between two groups.
P-values ≤0.05 were considered significant. One-way
ANOVA was used for multiple analyses of more than two
groups with the Tukey post hoc test.
Results
Estrogen increases amiloride-sensitive Isc in
M1-CCD cells
We tested the acute effect of E2 on the amiloride-sensi-
tive Isc in polarized M1-CCD cells. Basolateral addition
of E2 (25 nmol/L) induced an increase in the amiloride
(10 lmol/L) -sensitive Isc within 15 min of treatment
(Fig. 2A and B) and a decrease in the amiloride-insensi-
tive Isc (Fig. 2A and C). The activity of the Na+/K+-AT-
Pase pump, localized at the basolateral membrane in
M1-CCD cells, is critical to create the driving force nec-
essary for the transepithelial movement of Na+ ions.
Therefore, an increase in the Na+/K+-ATPase activity
could lead to an increase in the amiloride-sensitive trans-
epithelial Na+ currents. We investigated a possible effect
of E2 on the activity of the Na+/K+-ATPase as an expla-
nation for the increase in the amiloride-sensitive Isc
observed in M1-CCD cells. We found that E2, added
basolaterally, failed to stimulate the activity of the Na+/
K+-ATPase, as determined from the ouabain-sensitive
current after permeabilization of the apical membrane
with amphotericin B (50 lmol/L) (Fig. 3A and B). This
observation rules out the possibility of a direct acute
regulation of the Na+/K+-ATPase activity by E2 in
M1-CCD cells. Thus, it can be concluded that the stimu-
latory effect of E2 on the amiloride-sensitive Isc is due
to a direct regulation of ENaC and not secondary to
changes in Na+/K+-ATPase activity.
(A)
(B)
(C)
Figure 2. E2 increases the amiloride-sensitive Isc in M1-CCD cells.
Ussing chamber experiments revealed that treatment with E2
(25 nmol/L) acutely (15 min) increased the amiloride-sensitive Isc in
polarized epithelia of M1-CCD cells. (A) Representative Ussing
chamber experiment showing the effect of E2 on the amiloride-
sensitive Isc (open circles control conditions, close circles E2
treated). (B) Graph showing mean values for the amiloride-sensitive
Isc for control and E2-treated conditions (control, 1.9  0.2
lA/cm2; E2, 4.7  0.3 lA/cm2; n = 43, ***P < 0.001). (C) Graph
showing values for the amiloride-insensitive Isc (control,
5.1  0.6 lA/cm2; E2, 2.7  0.5 lA/cm2; n = 27, **P < 0.01)
2014 | Vol. 2 | Iss. 5 | e12020
Page 4
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
Estrogen Stimulates Na+ Absorption in Renal Cells Y. R. Yusef et al.
Estrogen increases amiloride-sensitive Isc
via activation of PKCd
Previous work from our laboratory demonstrated that E2
treatment produces a rapid antisecretory response in rat
colonic epithelia. This nongenomic effect was shown to be
dependent on the activation of PKCd (O’Mahony et al.
2007). On the basis of this observation, we investigated if
PKCd activation could be playing a role in the E2 proab-
sorptive response in CCD cells. E2 activation of PKCd was
tested using the inhibitor rottlerin. The reported IC50 for
the inhibition of PKCd by rottlerin is 3–6 lmol/L (Gsch-
wendt et al. 1994), and a concentration of 5 lmol/L was
used in our experiments. Caution must be exercised when
interpreting results with PKC inhibitors, although rottlerin
has been used as a PKCd inhibitor in hundreds of studies,
its specificity has been called into question in cell-based
assays (Soltoff 2007). That rottlerin inhibited PKCd activa-
tion in our cell system was confirmed by the rottlerin inhi-
bition of the E2-induced PKCd phosphorylation (Fig. 4).
We found that inhibition of PKCd with rottlerin abol-
ished the increase in amiloride-sensitive Isc induced by
E2 (Fig. 5A and B). These results indicate the involve-
ment of PKCd in transducing the stimulatory effect of E2
on ENaC in CCD cells. We therefore determined the
PKCd activation sensitivity to E2 from changes in the
PKCd phosphorylation state at residue Ser643. E2 rapidly
induced the activation of PKCd within 2 min which was
sustained over 2 h (Fig. 6A). The response was significant
at low concentrations well within the physiological range
of plasma levels of estrogen (0.1–0.8 nmol/L) (Fig. 6B).
Signaling pathways involved in E2-induced
PKCd activation
In breast cancer cells PKCd activity can be stimulated by
E2 through activation of matrix metalloproteinases
(MMPs) followed by the release of membrane-bound
heparin-binding epidermal growth factor (HB-EGF) and
trans-activation of the epidermal grow factor receptor
(EGFR) (Filardo et al. 2000). Here, we investigated the
possibility that PKCd can be activated in a similar fashion
in CCD cells. First, we performed experiments where
M1-CCD cells were treated for 30 min with the estrogen
receptor alpha (ERa) agonist PPT (1 nmol/L) or the
(A)
(B)
Figure 3. E2 does not increase the Na+/K+-ATPase activity in
M1-CCD cells. Ussing chamber experiments in amphotericin B
perforated epithelia using ouabain (100 lmol/L) demonstrated that
E2 does not affect the Na+/K+-ATPase pump current. (A)
Representative Ussing chamber experiment showing the effect of
E2 in the ouabain-sensitive Isc (open circles control conditions, close
circles E2 treated). (B) Graph showing mean values for the ouabain-
sensitive Isc for control and E2-treated conditions (control,
4.8  0.4 lA/cm2; E2, 6.3  1.4 lA/cm2; n = 4–7, P = 0.241).
Figure 4. The stimulatory effect of E2 on PKCd activity was
inhibited by rottlerin. M1-CCD monolayers were treated with
rottlerin (5 lmol/L) for 30 min prior to treatment with E2 (25 nmol/
L) for 15 min. Cells were then harvested for protein extraction and
subsequent Western blot analysis for phospho-PKCd. Top,
densitometric analysis for the expression of phospho-PKCd; bottom,
representative image of phospho-PKCd and b-actin expression
(n = 4, ***P < 0.001).
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estrogen receptor beta (ERb) agonist DPN (5 nmol/L).
We found that PPT but not DPN activated PKCd in a
similar fashion to E2 (Fig. 7A), indicating that ERa is the
receptor transducing PKCd activation by E2 in CCD cells.
Moreover, pretreatment of the CCD cell cultures with the
general ER antagonist ICI-182780 (100 nmol/L) inhibited
the stimulatory effect of E2 on the activity of PKCd
(Fig. 7B), reaffirming the involvement of at least one clas-
sical ER isoform in the process.
We next explored the possible involvement of MMP-
EGFR and downstream signaling pathways in the E2
activation of PKCd. Pretreatment of M1-CCD cells for
30 min with the broad spectrum inhibitor for MMPs
GM6001 (1 lmol/L), produced an antagonistic effect on
E2 activation of PKCd (Fig. 8A). Similar inhibition of
the E2 stimulatory effect on PKCd was obtained when
M1-CCD cells were pretreated either with the EGFR
inhibitor AG1478 (10 lmol/L) (Fig. 8B) or with the
PLC inhibitor U-73122 (10 lmol/L) (Fig. 8C). However,
we found that pretreatment with the PI3K inhibitor
LY-294002 (25 lmol/L) did not abolish the stimulation
of PKCd activity observed after acute treatment with E2
(Fig. 8D). Taken together, these results suggest that the
activation of PKCd induced by E2 in CCD cells is
mediated through the MMP-EGFR-PLC signaling path-
way.
(A)
(B)
Figure 5. E2 increases the amiloride-sensitive Isc in M1-CCD cells
via activation of PKCd. M1-CCD cells were pretreated for 30 min
with the PKCd inhibitor rottlerin (5 lmol/L). (A) Representative
Ussing chamber experiment showing the effect of E2 on the
amiloride-sensitive Isc (open circles, E2 treated; close circles, E2
treated + rottlerin). (B) Graph showing mean values for the
amiloride-sensitive Isc in the different conditions (control,
1.9  0.2 lA/cm2; rottlerin alone, 1.1  0.5 lA/cm2; E2,
4.4  0.8 lA/cm2; E2 + rottlerin, 1.1  0.6 lA/cm2; n = 6,
**P < 0.01).
(A)
(B)
Figure 6. Time and dose dependence of PKCd activation by E2.
Western blot showing PKCd autophosphorylation at residue Ser643
following E2 treatment. (A) Time dependence (n = 4, *P < 0.05,
**P < 0.01, and ***P < 0.001 compared with the control). (B)
Dose dependence (n = 4, *P < 0.05, **P < 0.01, and ***P < 0.001
compared with the control).
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ERa is involved in the E2 stimulation of
ENaC
The results presented above suggest that the activation of
PKCd is a necessary step for the stimulation of the
amiloride-sensitive Isc after acute treatment with E2; and
also indicate that the activation of ERa is required for the
stimulatory effect exerted by E2 on PKCd activity. Thus,
we hypothesized that ER activation could be required for
the PKCd-dependent stimulatory effect of E2 on ENaC.
We found that ER inhibition with the antiestrogen ICI-
182780 (100 nmol/L) for 30 min abolished the E2 effect
on the amiloride-sensitive Isc (Fig. 9A). Furthermore,
treatment with the specific ERa agonist PPT (1 nmol/L)
for 15 min had a similar effect to that observed following
E2 treatment (Fig. 9B). These results suggest that the acti-
vation of ERa is an essential step in the stimulation of
ENaC activity by E2.
E2 activation of ENaC is transduced via
MMP, EGFR, and PLC signaling
As the increase in the amiloride-sensitive Isc observed
after the acute treatment with E2 depends on PKCd acti-
vation, which is coupled to a signaling cascade including
the MMPs, EGFR, and PLC, we tested whether these three
signaling components also participate in the estrogen
stimulation of the amiloride-sensitive Na+ absorption in
CCD cells. E2 treatment failed to activate ENaC when
M1-CCD cells were pretreated for 30 min with the MMP
inhibitor GM6001 (1 lmol/L) (Fig. 10A). Similar inhibi-
tory effects on the ENaC current response to E2 were
observed after treatment with the EGFR inhibitor AG1478
(10 lmol/L) (Fig. 10B) or the PLC inhibitor U-73122
(Fig. 10C). These results further confirm the involvement
of the MMP signaling cascade, EGFR and PLC, not only
in the activation of PKCd but also in the ENaC activation
induced by E2.
Nuclear-excluded estrogen bound ER
activates ENaC in M1-CCD cells
Given the rapid response to E2, we reasoned that the hor-
mone effects on PKCd and ENaC were primarily nonge-
nomic in onset (the sustained responses may involve
transcriptional events). To test this hypothesis, we con-
ducted studies using an E2 dendrimer conjugate which
when bound to the estrogen receptor prevents its translo-
cation to the nucleus. In the past, E2 conjugated to mem-
brane impermeable carriers such as BSA have been used
to support the existence of membrane-associated ERs and
nongenomic responses. Criticism surrounding the stability
of these conjugates following internalization led to the
development of more stable conjugates such as the estro-
gen conjugate dendrimer (EDC) (Harrington et al. 2006).
This compound is composed of a dendrimer molecule
(PAMAM) that is coupled to ~20 molecules of estrogen,
allowing the EDC to interact at the plasma membrane
and enter the cytoplasm but not penetrate the nuclear
envelope, thus discriminating the genomic from the non-
genomic effects of E2 (Harrington et al. 2006). The effects
of EDC on the amiloride-sensitive Isc were compared
with free estrogen. Ussing chamber experiments where
M1-CCD cells were treated for 15 min with EDC at a
final concentration equivalent to 25 nmol/L of free E2
demonstrated that EDC stimulates ENaC activity in a
(A)
(B)
Figure 7. E2 activates PKCd through a mechanism involving ERa.
(A) PKCd activity was stimulated by the ERa selective agonist PPT
(1 nmol/L) but not by the ERb agonist DPN (5 nmol/L) (n = 4,
***P < 0.001 compared with the control). (B) E2 failed to stimulate
the activity of PKCd when M1-CCD cells were pretreated for
30 min with the general ER antagonist ICI-182780 (100 nmol/L)
(n = 4, ***P < 0.001 compared with the control).
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similar manner to unbound E2 (Fig. 11). These results
point to a rapid “nongenomic” response to estrogen
transduced at the membrane or in the cytosol by the
estrogen receptor ERa without requiring the receptor–
ligand complex entering the nucleus. This observation
does not exclude other later transcriptional events
occurring via the E2 activated EGFR pathway to cause
sustained activation of ENaC.
Estrogen rapidly increases the apical
membrane abundance of the c-ENaC subunit
in M1-CCD cells
A plausible explanation for the observed rapid increase in
the amiloride-sensitive Isc in M1-CCD cells after treat-
ment with E2 could result from changes in the abundance
of the different ENaC subunits at the apical plasma mem-
brane, similar to that described for the nongenomic
effects of aldosterone on ENaC subunits membrane abun-
dance in M1-CCD cells (McEneaney et al. 2010). To test
our hypothesis, we looked for changes in the total abun-
dance and surface expression of a-, b-, and c-ENaC
subunits using biotinylation, Western blotting, and
immunofluorescence. This analysis revealed that after
30 min treatment with E2, the a- and b-ENaC subunits
did not change either their total expression or apical
membrane abundance (Fig. 12). The c-ENaC total expres-
sion was also not significantly changed in response to E2
treatment; however, there was a significant increase in the
c-ENaC apical surface abundance (Fig. 13A). These
results were confirmed by immunolocalization experi-
ments (Fig. 13B and C).
Finally, we investigated whether PKCd activation was
involved in the acute increase in the apical surface abun-
dance of the c-ENaC subunit following E2 treatment.
Inhibition of PKCd using rottlerin (5 lmol/L) for 30 min
(A) (B)
(C) (D)
Figure 8. The MMP-EGFR signaling pathway is involved in the activation of PKCd induced by E2. (A) E2 failed to stimulate the activation of
PKCd when M1-CCD cells were pretreated for 30 min with the MMP inhibitor GM6001 (1 lmol/L) (n = 4, ***P < 0.001 compared with the
control). Similar results were observed for experiments where M1-CCD cells were pretreated for 30 min with (B) the EGFR inhibitor AG1478
(10 lmol/L) (n = 4, ***P < 0.001 compared to the control conditions) and (C) the PLC inhibitor U-73122 (10 lmol/L) (n = 4, **P < 0.01
compared with the control). (D) Pretreatment for 30 min with the PI3K inhibitor LY-294002 (25 lmol/L) did not abolish the stimulatory effect
of E2 on PKCd activity (n = 4, ***P < 0.001 compared with the control).
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abolished the increase in the apical membrane abundance
of c-ENaC normally observed with E2 (Fig. 13D).
These results suggest that the mechanism by which E2
stimulates the amiloride-sensitive Isc in M1-CCD cells is
related to its stimulatory effect on the abundance of
c-ENaC at the apical membrane and not to changes in
ENaC subunit protein expression. This process is depen-
dent on the activation of PKCd which plays a role in the
intracellular trafficking of c-ENaC to the apical plasma
membrane following E2 treatment.
Discussion
The normal functioning of the kidney is central to main-
taining fluid and electrolyte homeostasis of the whole
body. In the distal parts of the nephron, the activity of
(A)
(B)
Figure 9. ERa is involved in the stimulation of the amiloride-
sensitive Isc induced by E2. (A) When M1-CCD cells where
pretreated for 30 min with the ER antagonist ICI-182780
(100 nmol/L) there was no stimulation of the amiloride-sensitive Isc
by E2 (control, 2.8  0.4 lA/cm2; E2, 7.8  0.6 lA/cm2; E2 + ICI,
1.9  0.3 lA/cm2; ICI alone, 1.7  0.4 lA/cm2; n = 6,
***P < 0.001). Notice that ICI-182780 alone, which has GPER
agonist activity, failed to stimulate the amiloride-sensitive Isc,
indicating that GPER is unlikely to be involved in this process. (B)
Treatment with the ERa agonist PPT (1 nmol/L for 15 min)
increased the amiloride-sensitive Isc in a similar fashion to E2 in
polarized M1-CCD cells epithelia (control, 1.3  0.3 lA/cm2; E2,
4.0  0.4 lA/cm2; PPT, 3.7  0.3 lA/cm2; n = 5, **P < 0.01).
(A)
(B)
(C)
Figure 10. The increase in the amiloride-sensitive Isc induced by E2
depends on MMP activation, EGFR transactivation, and PLC
activation. (A) Ussing chamber experiments revealed that when
M1-CCD cells were pretreated for 30 min with the MMP inhibitor
GM6001 (1 lmol/L) there was no stimulation of the amiloride-
sensitive Isc induced by E2 (control, 1.7  0.5 lA/cm2; GM6001
alone, 2.0  0.3 lA/cm2; E2, 4.0  0.4 lA/cm2; E2 + GM6001,
1.9  0.3 lA/cm2; n = 5, **P < 0.01). Similar results were
observed for Ussing chamber experiments were M1-CCD cells were
pretreated for 30 min with (B) EGFR inhibitor AG1478 (10 lmol/L)
(control, 2.8  0.6 lA/cm2; AG1478 alone, 2.2  0.4 lA/cm2; E2,
5.3  0.8 lA/cm2; E2 + AG1478, 3.1  0.5 lA/cm2; n = 6,
*P < 0.05) or (C) PLC inhibitor U-73122 (10 lmol/L) (control,
1.3  0.3 lA/cm2; U-73122 alone, 1.0  0.4 lA/cm2; E2,
3.3  0.5 lA/cm2; E2 + U-73122, 1.3  0.4 lA/cm2; n = 5,
**P < 0.01).
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ENaC is the rate-limiting step for Na+ reabsorption and
accounts for the fine-tuning of Na+ content of the whole
body. This process is tightly regulated by steroidal and
nonsteroidal hormones such as aldosterone, vasopressin,
and insulin. The main aim of this study was to determine
whether E2 had an effect on Na+ reabsorption in cortical
collecting duct using M1-CCD cells. We found a com-
pletely novel action of estrogen to rapidly increase the
ENaC current in CCD cells through a nongenomic mech-
anism involving cytosolic or membrane-associated ERa,
MMP-dependent EGFR transactivation followed by PLC
activation, and PKCd phosphorylation to induce an
increase in the abundance of the c-ENaC subunit at the
apical membrane.
Aside from the rapidity of the response, our results are
qualitatively similar to the observations of chronic long-
term E2 treatment in alveolar and kidney cells (Sweezey
et al. 1998; Gambling et al. 2004). However, one study
found no estrogen effect in alveolar epithelial cells (Laube
et al. 2011), where treatment with E2 alone for between
48 and 72 h did not induce a significant increase in amil-
oride-sensitive currents; although it was also shown that
E2 and progesterone together increase the amiloride-sen-
sitive currents and mRNA levels for the a- and b-ENaC
subunits (Laube et al. 2011). Our data indicate that the
mechanism involved in the increase in amiloride-sensitive
currents induced by E2 in M1-CCD cells does not require
progesterone. It cannot be ruled that these differences are
due to a different cellular culture system which could
affect expression of the estrogen receptor, progesterone
receptor, or other proteins participating in the signaling
pathway.
The rapid E2 effect on ENaC activity suggests a mecha-
nism involving a nongenomic action that may augment the
transcriptional response in some tissues. The evidence for a
nongenomic response was strengthened by the observation
of an increase in the amiloride-sensitive current after treat-
ment with the estrogen dendrimer compound EDC, which
has been demonstrated to be a useful tool to dissect geno-
mic and nongenomic effects of E2 (Harrington et al. 2006).
The implication is that the early ENaC response to estrogen
Figure 11. EDC increases the amiloride-sensitive Isc. Ussing
chamber experiments where M1-CCD cells were treated with EDC
at a final concentration equivalent to 25 nmol/L of free E2. EDC,
but not the unconjugated dendrimer (EDCC), increased the
amiloride-sensitive Isc comparable to E2 (control, 1.7  0.1
lA/cm2; E2, 3.7  0.3 lA/cm2; EDC, 4.0  0.4 lA/cm2; EDCC,
2.3  0.4 lA/cm2; n = 5, **P < 0.01).
(A)
(B)
Figure 12. Acute treatment with E2 did not change the apical
membrane abundance of a- or b-ENaC. M1-CCD cells grown on
permeable supports were basolaterally treated with E2 (25 nmol/L)
for 15 min. The apical abundance of a- and b-ENaC was assessed
by biotinylation of apical proteins and subsequent Western blotting
using specific antibodies against a- or b-ENaC as indicated. (A) Top,
densitometric analysis for the apical abundance of a-ENaC; bottom,
a representative image for the biotinylated and total a-ENaC
expression as well as the expression of b-actin (n = 4, P = 0.405).
(B) Top, densitometric analysis for the apical expression of the
b-ENaC; bottom, a representative image for the biotinylated and
total b-ENaC expression, the expression of b-actin is also shown
(n = 6, P = 0.350).
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is initiated by a signaling event at the cell membrane.
Therefore, this process seems to be different in nature from
those previously described in the rat lung epithelia
(Sweezey et al. 1998) and rat kidney of female rats
(Gambling et al. 2004); where in both cases the increase in
the amiloride-sensitive current in response to E2 is associ-
ated with increase in the mRNA levels of a- and c-ENaC
subunits at least 8 h after treatment implying a genomic
effect (Horisberger 2003).
It has been recently shown that E2 evokes intracellular
Ca2+ transients and increases the H+-ATPase activity in
intercalated cells in mouse distal convoluted tubules, con-
necting tubules, and initial cortical collecting ducts via a
G-protein coupled estrogen receptor (GPER)-dependent
signaling pathway (Hofmeister et al. 2012). Our data,
showing that ICI-182780 (which is also a GPER agonist)
did not stimulate the amiloride-sensitive current, indi-
cates that GPER does not participate in the nongenomic
(A) (B)
(C) (D)
Figure 13. E2 rapidly increases the apical membrane surface abundance of c-ENaC. (A) Biotinylation experiments revealed that after 30 min
treatment with E2, there was a significant increase in the apical surface abundance of c-ENaC (n = 4, ***P < 0.001). In this set of experiments
the antibody specifically detected a band of approximately 75 kDa, corresponding to the cleaved form of c-ENaC. Immunostaining and confocal
microscopy experiments using a specific antibody recognizing c-ENaC (green) and the plasma membrane (red) confirmed these biotinylation
results. (B) In control conditions, c-ENaC was found in clusters present in the cytosol, the close proximity to the plasma membrane (white
arrows) and in the plasma membrane. (C) After acute treatment with E2, the c-ENaC fluorescence signal was predominately found in the
plasma membrane. Confocal Z-stack images are representative of three independent experiments. (D) Pretreatment for 30 min with the PKCd
inhibitor rottlerin (5 lmol/L) abolished the increase in the apical surface abundance of c-ENaC after treatment with E2 (n = 4, ***P < 0.001).
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response to E2 in M1-CCD cells. Moreover, our results
strongly suggest that an ERa isoform transduces the rapid
E2 effect on ENaC. Interestingly, a recent study has found
that the three ERa isoforms are expressed in the kidney
(Irsik et al. 2013). The same study showed that ERa36,
the membrane-associated isoform that mediates rapid
effects of E2 in other tissues (Pedram et al. 2009, 2013),
is highly expressed in the membrane fraction of the renal
cortex (Irsik et al. 2013). In our study we found that M1-
CCD cells monolayers express ERa and ERb (Fig. 14).
E2 produced an increase in the amiloride-sensitive
component of the transepithelial current and a decrease
in the amiloride-insensitive component of the current in
M1-CCD cells. These effects appear to be specific for
ENaC as both Ba2+-sensitive and the FSK-stimulated Isc
were not affected by E2 (Figs. 15 and 16, respectively),
thus ruling out K+ channels and cAMP-activated Cl
channels as estrogen targets in CCD cells. The expression
of Ca2+-activated Cl channels (CaCCs) has been found
in different renal cell types (Rajagopal et al. 2012; Buch-
holz et al. 2014; Faria et al. 2014). The lack of transepi-
thelial current response to carbachol observed in
M1-CCD cells under control and E2-treated conditions
(data not shown) suggest that CaCCs do not contribute
to the effect of E2 on transepithelial ion transport in
M1-CCD cells.
The effect of E2 to enhance the amiloride-sensitive INa
may be explained by the recent finding that ENaC chan-
nels composed of a and b subunits have a very high open
probability but a reduced sensitivity to amiloride com-
pared to those composed of either a and c or the three
ENaC subunits (Shi and Kleyman 2013). It is possible
that estrogen converts ENaC channels with low sensitivity
to amiloride (ENaC ab) to a more amiloride-sensitive
phenotype (ENaC abc) given our findings of increased
c subunit abundance in the apical membrane after E2
treatment. A higher expression of ENaC abc channels
could explain the apparent relative decrease in the amilo-
ride-insensitive component of the Isc. ENaC channels are
more sensitive to benzamil than amiloride and we com-
pared the dose–response of benzamil before and after
estrogen treatment. A significant increase in the sensitivity
of ENaC currents to benzamil was observed following E2
treatment (Fig. 17), suggesting that estrogen may enhance
the abundance of ENaC abc channels in the apical mem-
brane.
Previously published evidence suggests that PKCa acti-
vation leads to inhibition of ENaC activity (Stockand
Figure 14. M1-CCD cells monolayers express ERa and ERb at the
protein level. M1-CCD cell monolayers were harvested for protein
extraction and subsequent Western blotting using specific
antibodies against ERa and ERb, respectively.
(A)
(B)
Figure 15. Effect of acute treatment with E2 on the Ba2+-sensitive
current in M1-CCD polarized monolayers. (A) A representative
tracing of changes in Isc in control conditions and after basolateral
treatment of E2 (25 nmol/L) for 15 min, the responses after the
apical addition of Ba2+ (2 mmol/L) and amiloride (10 lmol/L) are
also shown. (B) Values for the Ba2+-sensitive Isc: Control,
2.1  0.3 lA/cm2; E2, 2.4  0.7 lA/cm2; n = 7, P = 0.765.
Figure 16. FSK-stimulated Isc was not affected by the acute
treatment with E2 in M1-CCD polarized monolayers. Values for the
FSK-stimulated Isc: Control, 4.2  0.3 lA/cm2; E2, 4.6  0.3
lA/cm2; n = 41, P = 0.332.
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et al. 2000; Awayda et al. 2002; Booth and Stockand
2003). However, the results presented here and those
published by others (Ali et al. 1998; Sun et al. 2012) sug-
gest that PKC activation can also lead to stimulation of
ENaC activity. This contradiction could be attributed to
differences in the expression and/or activation profiles of
the different PKC isozymes mediating these effects.
In previous studies we have demonstrated that E2 spe-
cifically activates PKCd to produce the antisecretory
response in distal colon (O’Mahony et al. 2007, 2009;
O’Mahony and Harvey 2008). In these studies, we
confirmed that rottlerin (up to a concentration of 10 lm)
did not inhibit PKCa, PKCb, or PKCe activation by E2
and that inhibition of these PKC isozymes did not
suppress the antisecretory response to E2. In this study
we found that rottlerin inhibited the E2-induced PKCd
autophosphorylation and activation in CCD cells (Fig. 4).
Thus, in our study, a rottlerin inhibitory effect on secre-
tion and absorption may be interpreted as specifically
involving PKCd.
The mechanism linking PKCd activity to the increase in
ENaC activity and apical surface expression of c-ENaC is
unclear. However, it has been shown that PKCd regulates
intracellular trafficking of ENaC subunits in M1-CCD cells
through a mechanism dependent on the activity of PKD1
(McEneaney et al. 2008). PKD1 is a serine/threonine
kinase that is activated through a nPKC-dependent path-
way (Gliki et al. 2002; Scaltriti and Baselga 2006) and has
been implicated in intracellular trafficking through its
function at the TGN to regulate the fission of vesicles spe-
cifically destined for the cell surface (Scaltriti and Baselga
2006). Thus, PKD1 could be the signaling component
mediating the increase in ENaC activity and apical surface
expression of c-ENaC subsequent to PKCd activation
by E2.
In this study, the c-ENaC antibody detected two bands,
one of 93 kDa, corresponding to the full length form,
and other of 75 kDa corresponding to either the cleaved
or the fully unglycosylated form of the subunit. In the
biotinylation experiments, the antibody specifically
detected a band at 75 kDa, which probably corresponds
to the cleaved form of the c-ENaC subunit (Fig. 1C). The
a-ENaC antibody detected only the full length form
(95 kDa) of a-ENaC (Fig. 1A). Hence, we were unable to
test the possibility of a change in the proportion between
the full and cleaved forms of either the a- or c-ENaC
subunits at the apical membrane in response to E2.
Nevertheless, the results from the immunostaining experi-
ments suggest that E2 response is driven by stimulation
of the trafficking of c-ENaC toward the apical membrane.
It is most probable that E2 stimulates the trafficking of all
ENaC subunits together to the membrane as channel for-
mation is unlikely to occur through subunit complex
aggregation in the membrane.
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Figure 17. Benzamil dose–response curves. Increasing
concentrations of benzamil were added to the apical side of
polarized M1-CCD cells under control (open circles) and E2-treated
(close circles) conditions. Changes in the amplitude of the Isc were
recorded in Ussing chambers. The Isc was normalized to the basal
Isc in the absence of benzamil. The calculated values for IC50 were
36.20  6.98 nmol/L (control) and 10.45  1.92 nmol/L (E2)
(n = 9). The IC50 values were estimated by fitting the following
equation y = 1/(1 + 10[log IC50  log X]).
Figure 18. Schematic representation showing the proposed
signaling pathways involved in activation of ENaC following acute
treatment with E2 in cortical collecting duct M1-CCD cells.
Following the binding of E2 to ERa, the activation of MMPs
stimulates the release of HB-EGF. Next, HB-EGF binds EGFR
inducing the trans-activation of the receptor and subsequent
increase in the activity of PLC. The rise in DAG levels, produced by
the activation of PLC, leads to activation of PKCd which, in turn,
increases the apical surface abundance of the c-ENaC subunit and
the activity of ENaC in the apical membrane of CCD cells.
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In conclusion, this study describes a novel function for
estrogen as a salt-retaining hormone in kidney cortical
collecting duct cells and provides molecular mechanistic
insights into its mode of action on ENaC in distal renal
tubule cells (Fig. 18). The effects of estrogen on ENaC
may be additive or separate from aldosterone regulation.
The study provides evidence for the involvement of the
“aldosterone-sensitive CCD” to effect an increased whole
body fluid volume observed in high estrogen states.
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